The closely held group is working with advisers to sell Cypress’s two holdings: the chemicals companies IPS Corp. and Encapsys, said the people, who asked not to be identified because they weren’t authorized to speak publicly. IPS is expected to fetch about $1.2 billion while Encapsys could be worth about $750 million, the people said. IPS will be sold first, they added.
Representatives for Sherman, ...
Learn more about Bloomberg Law or Log In to keep reading:
See Breaking News in Context
Bloomberg Law provides trusted coverage of current events enhanced with legal analysis.
Already a subscriber?
Log in to keep reading or access research tools and resources.